Though the 2014 ebola outbreak has been relatively contained, there is still no vaccine or treatment specifically built for the disease. Since the drug development process can take over a decade, medical personnel faced with emergency outbreaks often face this problem. However, repurposing research at the US Army Medical Research Institute of Infectious Diseases has revealed that two drugs already on pharmacy shelves may be effective ebola treatments. Zoloft, an antidepressant, and Vascor, a chest pain drug that is no longer sold in the United States, both showed potential for treating ebola in humans. Clinical trials have not yet begun, but researchers believe that the repurposed drugs show promise in combatting this dangerous condition.
Alzheimer's disease American Chemical Society antihistamine athlete's foot BBC Belviq breast cancer Brown University cancer Case Western Reserve University cocaine colorectal cancer diabetes diamond blackfan anemia disease drug addiction drug repositioning drugrepurposing drug repurposing eczema hepatitis C Hiroshima University immune system Insilico Medicine leukemia drug malaria MRSA multiple sclerosis Nature nervous system obesity Parkinson's disease pathogens prostate cancer radiation saccharin skin scarring Stanford University tapeworm TIME treatment University of Florida University of Texas Viagra Yale University